|
Hot Stocks
|
Sandoz Canada announced a… ShowHide Related Items >><< - 06/30/22
- Novartis says data show tislelizumab significantly extended median OS in ESCC
- 06/24/22
- Novartis granted orphan status for malignant glioma treatment
- 06/24/22
- Novartis receives positive CHMP opinion for Scemblix
- 06/23/22
- Novartis says FDA grants accelerated approval for Tafinlar + Mekinist
- 06/29/22 Deutsche Bank
- Novartis price target lowered to CHF 75 from CHF 80 at Deutsche Bank
- 06/03/22 Oppenheimer
- Turning Point Therapeutics downgraded to Perform from Outperform at Oppenheimer
- 05/13/22 Piper Sandler
- Point Biopharma price target lowered to $14 from $17 at Piper Sandler
- 05/13/22 Jefferies
- Roche downgraded to Hold from Buy at Jefferies
- 04/26/22
- Novartis sees 2022 core operating income to grow mid single digit
- 04/26/22
- Novartis reports Q1 core EPS $1.46, consensus $1.46
- 02/02/22
- Novartis sees 2022 sales, core operating income up mid single digit
- 02/02/22
- Novartis reports Q4 core EPS $1.40 vs. $1.34 last year
- 06/30/22
- Novartis favoring spinoff of $25B Sandoz unit, Bloomberg reports
- 06/30/22
- Novartis said to lean toward Sandoz spinoff over sale, Bloomberg says
- 06/28/22
- Novartis to cut up to 8,000 jobs, or 7% of workforce, in restructuring
- 06/28/22
- Novartis planning to cut up to 1,400 jobs in Switzerland, Reuters reports
- 06/30/22
- What You Missed On Wall Street On Thursday
- 06/30/22
- What You Missed On Wall Street This Morning
- 06/28/22
- What You Missed On Wall Street On Tuesday
- 01/19/22
- Meet Sangamo: Fly exclusive interview with CEO Sandy Macrae, COO Mark McClung
|
|
Recommendations
| ShowHide Related Items >><< - 05/25/22
- Capricor Therapeutics appoints Avat as Chief Business Officer
- 03/31/22
- Edwards Lifesciences' Mitris Resilia valve approved by FDA
- 01/27/22
- Edwards Lifesciences falls -8.3%
- 06/08/22 Citi
- Edwards Lifesciences removed from North America Focus List at Citi
- 05/17/22 Citi
- Edwards Lifesciences price target lowered to $115 from $134 at Citi
- 04/27/22 Canaccord
- Edwards Lifesciences price target lowered to $137 from $152 at Canaccord
- 04/27/22 Citi
- Edwards Lifesciences price target lowered to $134 from $138 at Citi
- 04/26/22
- Edwards Lifesciences backs FY22 adjusted EPS $2.50-$2.65, consensus $2.55
- 04/26/22
- Edwards Lifesciences reports Q1 adjusted EPS 60c, consensus 57c
- 04/26/22
- Notable companies reporting after market close
- 01/26/22
- Edwards Lifesciences backs FY22 adjusted EPS $2.50-$2.65, consensus $2.58
- 04/26/22
- Fly Intel: After-Hours Movers
- 03/16/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/26/22
- Fly Intel: After-Hours Movers
|
|
Options
| ShowHide Related Items >><< - 07/01/22
- Amazon to update cancellation practices in line with EU consumer rules
- 06/30/22
- BlackBerry Radar now available on AWS Marketplace
- 06/22/22
- Zscaler expands relationship with Amazon Web Services
- 06/22/22
- Carrols Restaurant appoints Filsoof as VP of Strategic Initiatives
- 06/30/22
- User reports indicate problems at Twitter, Downdetector says
- 06/22/22
- Twitter says it's 'testing a way to write longer on Twitter'
- 06/21/22
- Twitter board unanimously recommends shareholders vote for deal with Musk
- 06/16/22
- Twitter CFO sells $190K in common stock
- 08:26 Today
- Tesla's board urgers shareholders to 'vote against' reports into harassment
- 07/04/22
- Fly Intel: Top five weekend stock stories
- 07/02/22
- Tesla reports Q2 deliveries of 254,695, says June highest production month
- 06/29/22
- Tesla exec sells $2.62M in common stock
- 06/22/22
- AMD appoints Mathew Hein as chief strategy officer
- 06/12/22
- Fly Intel: Top five weekend stock stories
- 06/10/22
- AMD CEO: We're laser focused on technology leadership
- 06/09/22
- AMD announces Technology and Product Portfolio updates
- 06/29/22 JPMorgan
- Amazon.com price target lowered to $175 from $200 at JPMorgan
- 06/29/22 Redburn
- Microsoft initiated with a Buy at Redburn
- 06/29/22 Redburn
- Amazon.com initiated with a Buy at Redburn
- 06/29/22 Wolfe Research
- Amazon.com price target lowered to $140 from $145 at Wolfe Research
- 06/29/22 Wedbush
- Twitter assumed with a Neutral at Wedbush
- 06/06/22 Gordon Haskett
- Ira Sohn conference may bring news on FTX and Robinhood, says Gordon Haskett
- 06/02/22 Piper Sandler
- Twitter price target raised to $54.,20 from $51.50 at Piper Sandler
- 05/24/22 Jefferies
- Twitter price target lowered to $40 from $48 at Jefferies
- 08:11 Today Oppenheimer
- Oppenheimer remains bullish on Tesla following Q2 deliveries
- 07:26 Today Wedbush
- Wedbush sees focus on 2H trajectory after Tesla's 'ugly' delivery numbers
- 06:53 Today Deutsche Bank
- Tesla reported 'respectable' Q2 deliveries, says Deutsche Bank
- 06:03 Today JPMorgan
- Tesla price target lowered to $385 from $395 at JPMorgan
- 06/30/22 Northland
- AMD upgraded to Outperform at Northland following multiple compression
- 06/30/22 Northland
- AMD upgraded to Outperform from Market Perform at Northland
- 06/29/22 BofA
- AMD price target lowered to $110 from $160 at BofA
- 06/22/22 Morgan Stanley
- AMD resumed with an Overweight at Morgan Stanley
- 05/05/22
- AES Corp.to provide 450 MW of renewable energy to Amazon
- 04/28/22
- Amazon sees Q2 revenue $116B-$121B, consensus $125.55B
- 04/28/22
- Amazon reports Q1 EPS ($7.56) with Rivian expense, consensus $8.36
- 04/28/22
- Notable companies reporting after market close
- 04/28/22
- Twitter withdrawing previously provided outlook given pending acquisition
- 04/28/22
- Twitter reports Q1 EPS 90c, consensus 3c
- 02/10/22
- Twitter expects FY22 revenue growth in low to mid 20's range
- 02/10/22
- Twitter sees Q1 revenue $1.17B-$1.27B, consensus $1.26B
- 04/20/22
- Tesla reports Q1 EPS $3.22, consensus $2.26
- 04/20/22
- Notable companies reporting after market close
- 01/26/22
- Tesla reports Q4 non-GAAP EPS $2.54, consensus $2.26
- 01/26/22
- Notable companies reporting after market close
- 05/03/22
- AMD raises FY22 revenue view to $26.3B from $21.5B, consensus $25.15B
- 05/03/22
- AMD sees Q2 revenue $6.5B, plus or minus $200M, consensus $6.38B
- 05/03/22
- AMD reports Q1 EPS $1.13, consensus 91c
- 05/03/22
- Notable companies reporting after market close
- 06/30/22
- Amazon, Rite Aid limit purchase of emergency contraceptives, AP reports
- 06/29/22
- Amazon moves to restrict LGBTQ-related products in UAE, NY Times says
- 06/29/22
- Jim Chanos tells FT data center REITs 'our big short right now'
- 06/28/22
- Amazon limits buying of emergency contraceptive pills, Reuters says
- 08:43 Today
- Twitter launches legal challenge to Indian government blocking orders, FT says
- 06/30/22
- Twitter snags new partnership boss away from NBCUniversal, Bloomberg says
- 06/28/22
- Analyzing Twitter's 'firehose' of tweets won't be easy, WSJ reports
- 06/24/22
- Twitter giving Elon Musk even more user data, Insider reports
- 05:43 Today
- Tesla supplier Ganfeng Lithium probed for insider trading in China, FT reports
- 07/04/22
- German agency says 59k Tesla vehicles have software glitch, Reuters reports
- 07/01/22
- SOC Investment requests SEC investigate Tesla over board plans, CNBC says
- 07/01/22
- Tesla faces new lawsuit over racial abuse, Reuters reports
- 06/11/22
- Intel's problems haven't gone away, Barron's says
- 02/13/22
- Best-performing chip stock Synaptics still a buy, Barron's says
- 02/01/22
- China to launch platform for collaboration with Intel, AMD, Nikkei reports
- 01/20/22
- Xilinx-AMD deal on course for approval from China's SAMR, Dealreporter says
- 07/02/22
- Opening Day: Ivanhoe Electric falls in debut after raising $169M in IPO
- 06/29/22
- What You Missed On Wall Street On Wednesday
- 06/29/22
- #SocialStocks: Pinterest taps former Google executive as CEO
- 06/29/22
- What You Missed On Wall Street This Morning
- 06/29/22
- #SocialStocks: Pinterest taps former Google executive as CEO
- 06/24/22
- What You Missed On Wall Street On Friday
- 06/24/22
- What You Missed On Wall Street This Morning
- 06/22/22
- What You Missed On Wall Street On Wednesday
- 07/01/22
- What You Missed On Wall Street On Friday
- 07/01/22
- What You Missed On Wall Street This Morning
- 06/29/22
- What You Missed On Wall Street On Wednesday
- 06/29/22
- #SocialStocks: Pinterest taps former Google executive as CEO
- 07/01/22
- Here's What You Missed in Crypto This Week
- 06/30/22
- What You Missed On Wall Street On Thursday
- 06/30/22
- What You Missed On Wall Street This Morning
- 06/30/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 07/01/22
- Notable open interest changes for July 1st
- 07/01/22
- Amazon call buyer realizes 68% same-day gains
- 06/29/22
- Early notable gainers among liquid option names on June 29th
- 06/29/22
- Notable open interest changes for June 29th
- 06/16/22
- Early notable gainers among liquid option names on June 16th
- 06/03/22
- Early notable gainers among liquid option names on June 3rd
- 05/18/22
- Notable open interest changes for May 18th
- 05/17/22
- Notable open interest changes for May 17th
- 07/01/22
- Notable open interest changes for July 1st
- 06/28/22
- Notable open interest changes for June 28th
- 06/27/22
- Notable open interest changes for June 27th
- 06/23/22
- Notable open interest changes for June 23rd
- 06/30/22
- Notable open interest changes for June 30th
- 06/29/22
- Notable open interest changes for June 29th
- 06/24/22
- Notable open interest changes for June 24th
- 06/09/22
- Notable open interest changes for June 9th
|
|
Recommendations
| ShowHide Related Items >><< - 06/22/22
- Becton Dickinson announces voluntary recall of intraosseous products
- 06/13/22
- Becton Dickinson announces collaboration with Mayo Clinic Platform
- 06/08/22
- Becton Dickinson, CerTest Biotec enter collaboration on Monkeypox test
- 06/07/22
- Becton Dickinson appoints Simon Campion as Medical segment president
- 06/24/22 Wells Fargo
- Wells Fargo upgrades 'excellent defensive name' Becton Dickinson to buy
- 06/24/22 Wells Fargo
- Becton Dickinson upgraded to Overweight from Equal Weight at Wells Fargo
- 06/21/22 BofA
- Embecta initiated with an Underperform at BofA
- 06/06/22 Stifel
- Becton's Parata deal 'another positive step forward,' says Stifel
- 05/05/22
- Becton Dickinson raises FY22 adj. EPS view to $12.85-$13.00 from $12.80-$13.00
- 05/05/22
- Becton Dickinson reports Q2 adjusted EPS $3.18, consensus $2.99
- 02/03/22
- Becton Dickinson ups FY22 adjusted EPS view to $12.80-$13.00 from $12.30-$12.50
- 02/03/22
- Becton Dickinson reports Q1 adjusted EPS $3.64, consensus $2.85
- 06/24/22
- What You Missed On Wall Street On Friday
- 06/24/22
- What You Missed On Wall Street This Morning
- 06/24/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/18/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 04/01/22
- One new option listing and two option delistings on April 1st
|
|
Recommendations
| ShowHide Related Items >><< - $110.25 /
+1.535 (+1.41%) - 06/22/22
- FDA says investigating new complaint of death after infant had Abbott product
- 06/22/22
- FDA updates on efforts to increase supply and availability of infant formula
- 06/05/22
- Fly Intel: Top five weekend stock stories
- 06/05/22
- Late-Breaking data show Abbott FreeStyle Libre 3 System most accurate 14-day CGM
- $110.25 /
+1.535 (+1.41%) - 06/24/22 BTIG
- Abbott price target lowered to $130 from $140 at BTIG
- 06/01/22 Lake Street
- Abbott approval for Libre 3 'a huge positive' for Tandem, says Lake Street
- 05/31/22 Piper Sandler
- Abbott approval bodes well for DexCom, Tandem, says Piper Sandler
- 05/31/22 Stifel
- DexCom M&A response should put an end to recent dislocation, says Stifel
- $110.25 /
+1.535 (+1.41%) - 05/16/22
- Abbott backs FY22 adjusted EPS view 'of at least' $4.70, consensus $4.88
- 04/20/22
- Abbott backs FY22 adjusted EPS view at least $4.70, consensus $4.83
- 04/20/22
- Abbott reports Q1 adjusted EPS $1.73, consensus $1.46
- 04/19/22
- Notable companies reporting before tomorrow's open
- $110.25 /
+1.535 (+1.41%) - 06/16/22
- Abbott halts production at baby formula plant following storms, WSJ reports
- 06/09/22
- Abbott received employee complaint on plant earlier than known, WSJ reports
- 06/06/22
- Abbott resumes production in Michigan, formula shortage to continue, WSJ report
- 06/05/22
- Abbott restarts baby formula production at Michigan plant, CNBC says
- $110.25 /
+1.535 (+1.41%) - 06/16/22
- What You Missed On Wall Street This Morning
- 06/16/22
- Fly Intel: Pre-market Movers
- 06/06/22
- What You Missed On Wall Street On Monday
- 06/06/22
- What You Missed On Wall Street This Morning
- $110.25 /
+1.535 (+1.41%) - 06/22/22
- Abbott put volume heavy and directionally bearish
- 02/18/22
- Abbott put volume heavy and directionally bearish
- 01/31/22
- Unusually active option classes on open January 31st
- 01/26/22
- Unusually active option classes on open January 26th
|
|
Downgrade
| ShowHide Related Items >><< - 05/12/22 Scotiabank
- Dexterra Group price target lowered to C$10 from C$11 at Scotiabank
- 05/12/22 Raymond James
- Dexterra downgraded to Outperform from Strong Buy at Raymond James
- 05/11/22 TD Securities
- Dexterra Group price target lowered to C$9 from C$11.50 at TD Securities
- 03/11/22 National Bank
- Dexterra Group price target lowered to C$13 from C$14.50 at National Bank
|
|
Recommendations
| ShowHide Related Items >><< - 02/01/22
- Waters acquires charge detection mass spectrometry technology
- 05/17/22 Barclays
- Waters initiated with an Overweight at Barclays
- 05/17/22 BofA
- Waters upgraded to Neutral from Underperform at BofA
- 04/25/22 Wells Fargo
- Waters upgraded to Equal Weight from Underweight at Wells Fargo
- 02/02/22 Wells Fargo
- Waters price target lowered to $320 from $350 at Wells Fargo
- 05/03/22
- Waters sees Q2 adjusted EPS $2.55-$2.65, consensus $2.78
- 05/03/22
- Waters raises FY22 adjusted EPS view to $11.90-$12.10 from $11.75-$12.00
- 05/03/22
- Waters reports Q1 adjusted EPS $2.80, consensus $2.32
- 02/01/22
- Waters sees Q1 adjusted EPS $2.25-$2.35, consensus $2.38
- 05/03/22
- Early notable gainers among liquid option names on May 3rd
|
|
Hot Stocks
|
Expion360 has introduced… ShowHide Related Items >><< - 06/09/22
- Expion360 signs LOI to purchase lithium battery manufacturing equipment
- 05/19/22
- Expion360 appoints Greg Aydelott as CAO
- 05/05/22
- Expion360 expands reseller network with battery marketer, distributor
- 05/03/22
- Expion360 secures $300,000 line of credit from GM Financial
- 06/14/22
- Camping World buys Anthem RV in New River, AZ, no terms
- 05/23/22
- Camping World to acquire Richardson's RV Centers
- 05/19/22
- Camping World director buys $284K in common stock
- 02/22/22
- Camping World boosts regular quarterly dividend by 25%
- 05/05/22 Baird
- Camping World price target lowered to $35 from $40 at Baird
- 05/04/22 Raymond James
- Camping World price target lowered to $40 from $45 at Raymond James
- 04/13/22 DA Davidson
- Camping World initiated with a Neutral at DA Davidson
- 03/02/22 Truist
- Camping World cut to Hold at Truist on more cautious stance toward RV space
- 05/13/22
- Expion360 reports Q1 EPS (16c) vs. (10c) last year
- 05/03/22
- Camping World reports Q1 EPS $1.15, consensus $1.38
- 02/22/22
- Camping World reports Q4 adjusted EPS 90c, consensus 84c
|
|
Recommendations
| ShowHide Related Items >><< - 05/31/22
- Stryker receives FDA clearance for Q guidance system for spine applications
- 05/05/22
- Stryker announces board changes following annual meeting of shareholders
- 04/11/22
- Stryker says CMS grants outpatient facility code for InSpace implant
- 04/06/22
- Spruce Point names Stryker as short target, sees 35%-75% downside risk
- 05/17/22 Citi
- Stryker price target lowered to $280 from $310 at Citi
- 05/03/22 Piper Sandler
- Piper raises Zimmer Biomet target to $130, but sees 'better large caps to own'
- 05/02/22 Truist
- Stryker price target lowered to $280 from $296 at Truist
- 04/29/22 Piper Sandler
- Stryker price target lowered to $290 from $315 at Piper Sandler
- 04/28/22
- Stryker sees FY22 EPS at lower end of $9.60-$10.00 range, consensus $9.76
- 04/28/22
- Stryker reports Q1 EPS $1.97, consensus $1.95
- 04/28/22
- Notable companies reporting after market close
- 03/07/22
- Stryker still sees FY22 EPS $9.60-$10.00, consensus $9.79
- 04/06/22
- Spruce Point sees 35%-75% downside risk in Stryker shares
- 04/06/22
- Spruce Point announces short position in Stryker with 'Strong Sell' rating
- 04/06/22
- What You Missed On Wall Street On Wednesday
- 04/06/22
- What You Missed On Wall Street This Morning
- 03/16/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/27/22
- Fly Intel: After-Hours Movers
- 04/19/22
- Early notable gainers among liquid option names on April 19th
|
|
Hot Stocks
| ShowHide Related Items >><< - 06/06/22
- Zentek provides updates on ZenGUARD patent status
- 05/26/22
- Zentek opens industrial scale ZenGUARD facility in Ontario
- 05/19/22
- Zentek's Rapid Diagnostic Platform receives two NSERC grants
- 05/16/22
- Zentek appoints Wendy Ford as CFO
- 06/30/22 Lake Street
- Zentek initiated with a Buy at Lake Street
|
